The alpha(v)beta(3) integrin mediates endothelial cell binding to the extra
cellular matrix and transduces an intracellular signal promoting survival o
f endothelial cells and various tumor cells. While the alpha(v)beta(3) inte
grin-mediated survival signal has been shown to be adhesion dependent, a th
orough analysis has not been performed comparing the biochemical effects of
antagonist binding to alpha(v)beta(3) integrin with the effects induced by
the growth of cells in suspension. In this study we demonstrate that expre
ssion of alpha(v)beta(3) integrin in human embryonic kidney 293 cells trans
fers the alpha(v)beta(3) integrin survival pathway to an epithelial cell li
ne. Furthermore, we show that alpha(v)beta(3) integrin-expressing cells res
pond differently to alpha(v)beta(3) integrin-specific antagonist treatment
and growth in suspension conditions. Treatment with the alpha(v)beta(3) ant
agonist echistatin resulted in an apoptotic response occurring prior to cel
l detachment and was not observed in either suspended cells or antagonist-t
reated suspended cells. These data suggest that the death induced by antago
nist binding to alpha(v)beta(3) integrin results in an apoptotic signal wit
h different kinetics than the apoptotic signal induced by matrix detachment
(anoikis). Since aberrant alpha(v)beta(3) integrin expression in tumor mod
els is thought to play a role in tumor cell survival, these data have impli
cations for the use of alpha(v)beta(3) antagonists as anti-tumor agents. (C
) 1999 Academic Press.